February 19, 2015
Authored and Edited by Daniel F. Klodowski; Aaron L. Parker
The PTAB continues to be a highly popular venue for patent validity challenges, with final written decisions in post-grant proceedings being largely concentrated in the fields of electrical and mechanical engineering. This suggests a consistent trend in the types of technologies frequently challenged before the Board.
The USPTO allocates each post-grant proceeding to a Technology Center based on which art unit and technology center the patent was examined in during prosecution. The top three technology centers for IPR and CBM final written decisions as of February 1, 2015, are 2800 (Semiconductors, Electrical and Optical Systems and Components) with 41 decisions, 3600 (Transportation, Construction, Electronic Commerce, Agriculture, National Security and License & Review) with 41 decisions (of which 15 are CBM final written decisions, which accounts for the largest share of CBM final written decisions in any technology center), and 2100 (Computer Architecture Software and Information Security) with 32 decisions.
By contrast, technology centers 1600 (Biotechnology and Organic Chemistry) and 1700 (Chemical and Materials Engineering) combine for less than 20% of the final written decisions issued thus far.
Special thanks to Kai Rajan, Elliot Cook, Joseph Schaffner, and Cara Lasswell for their help with statistics, support, and the overall Finnegan PTAB statistics project.
Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.